ProteNano-MAG · Eco-friendly and bioinspired protein-based synthesis of magnetic nanomaterials for advanced cancer theranostics
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2023-06-01 → 2026-05-31
- EU contribution
- €181,153
- Participants
- 3
- Scheme
- HORIZON-TMA-MSCA-PF-EF
Lines connect the coordinator with its partners.
Results in brief
Eco-friendly and bioinspired protein-based synthesis of magnetic nanomaterials for advanced cancer theranostics
The ProteNano-MAG project vision encompasses the creation of eco-friendly and bioinspired protein-based magnetic nanomaterials designed to improve the diagnosis and treatment of cancer, one of the most pressing health challenges worldwide. Cancer remains the second leading cause of death globally, and despite great advances in therapy and early detection, there is an urgent need for more efficient, sensitive, selective, and sustainable biomedical tools. ProteNano-MAG brings together nanotechnology, protein engineering, and biomedical sciences to develop green synthesis routes for magnetic nanoparticles that are safe for patients and environmentally responsible in their production. The project draws inspiration from magnetotactic bacteria, microorganisms capable of producing highly uniform magnetic crystals known as magnetosomes. These natural nanoparticles exhibit outstanding magnetic and structural properties because their formation is guided by specialised proteins. ProteNano-MAG translates this biological precision into an artificial but sustainable system: engineered proteins act as templates that replicate the natural mineralisation process under mild, eco-friendly conditions. By combining biological design principles with nanofabrication, the project demonstrates how materials can be produced without toxic reagents or extreme processing, aligning with the European Green Deal and the Sustainable Development Goals. This innovative approach advances the field of nanomedicine by generating magnetic nanoparticles that can perform dual diagnostic and therapeutic functions. The resulting nanomaterials are expected to have potential to enhance MRI image quality, deliver drugs to specific tumour sites, and generate localised heat under an alternating magnetic field to kill cancer cells, three key functionalities for future personalised medicine. The objectives of ProteNano-MAG are: 1. To design and optimise engineered proteins based on the consensus tetratricopeptide repeat (CTPR) scaffold to guide the synthesis of iron-oxide/protein nanohybrids with sizes around 5 nm, suitable as positive contrast agents for Magnetic Resonance Imaging (MRI) and as multifunctional therapeutic platforms. 2. To develop bioinspired synthesis routes that mimic the natural formation of magnetosomes in bacteria by using synthetic nanoreactors such as lipid vesicles, enabling the controlled preparation of single-domain magnetic nanoparticles with high purity and magnetic performance. 3. To control and tune nanoparticle morphology through protein design, identifying the shapes and magnetic characteristics that maximise heating efficiency for cancer hyperthermia applications. ProteNano-MAG contributes to the EU’s mission to promote responsible, sustainable, and socially relevant innovation in healthcare. By demonstrating that high-performance nanomaterials can be produced through green and bioinspired approaches, the project opens new avenues for environmentally conscious nanotechnology and strengthens Europe’s leadership in next-generation biomedical research.
Data: CORDIS, © European Union
Project objective
The key goals of “ProteNano-MAG” are: (a) the training of a talented researcher, Dr. Lourdes Marcano, in the fast-growing field of science, technology and industrial applications of nanomedicine, where the host and partner institutions have critical knowledge and expertise; and, (b) the design, development and optimisation of eco-friendly synthesis routes using bioinspired simplified engineered proteins as templates for the preparation of magnetic nanoparticles for effective diagnosis and therapeutic intervention in cancer treatment. The interdisciplinary training program includes protein engineering, preparation of magnetic nanomaterials, characterization including sophisticated synchrotron-related techniques, in-vitro studies, magnetic resonance imaging and implementation for hyperthermia applications. The fellow is a talented researcher who has gained much expertise in biological synthesis mediated by magnetotactic bacteria (natural systems which are inspiration to “ProteNano-MAG”) and structural and magnetic characterization of single-domain magnetic nanoparticles during her undergraduate and postgraduate career. To further boost her career, she needs to gain expertise in alternative routes for the preparation of magnetic nanomaterials, design and characterization of recombinant simplified protein systems and state-of-the-art techniques such as space-resolved X-ray fluorescence and absorption spectroscopies, fields in which the CIC biomaGUNE and the two secondment’ co-hosts, the ESRF and the Universität Bayreuth, have a world-recognised expertise. Additionally, through the six-month placement at Resonant Circuits Ltd., the fellow will gain additional high-level training in magnetic hyperthermia for the medical/industrial application of the prepared magnetic nanoparticles. This multidisciplinary project will also increase her supervision experience, project and intellectual property management expertise, and research funding and proposal writing skills.
Original text from CORDIS.
Participants
Links
Data: CORDIS, © European Union
